Back to All

Cancer is a Mitochondrial Metabolic Disease: Not a Genetic Disease

Cancer and Autoimmune Disorders

Presented by: Thomas Seyfried, PhD

Original Presentation Date: September 15, 2022

Take the Course This course is available for CE Credit as a "Members Only" benefit. Not a Member? CLICK HERE to learn more about AAOSH Membership.

Course Description:

Join Dr. Thomas Seyfried, a prominent figure at Boston College, as he unveils groundbreaking insights challenging conventional cancer treatment paradigms. Discover how cancer can be fundamentally perceived as a single disease with a common underlying mechanism involving mitochondrial dysfunction. Gain empowering knowledge to address the root causes of cancer, aiming for healthier treatment and prevention approaches free from chemicals, drugs, and side effects. Dr. Seyfried advocates a whole-body approach to managing cancer cell growth and progression, offering a revolutionary perspective in conquering cancer without conventional pharmaceutical interventions.

Learning Objectives:

  • Recognize and differentiate the primary view of cancer as a mitochondrial metabolic disease rather than solely a genetic ailment, elucidating the significance of this paradigm shift in cancer treatment approaches.
  • Identify the core nature of cancer as a disease rooted in defective respiration with compensatory fermentation, transcending cellular and genetic variations, altering perceptions of the fundamental nature of cancer.
  • Understand the role of Ketogenic Metabolic Therapy (KMT) as a cost-effective, non-toxic therapeutic approach specifically targeting and eradicating tumor cells while preserving and enhancing the energy efficiency of normal cells, offering potential implications for cancer treatment.

Speaker Bio: 

Thomas N. Seyfried is a Professor of Biology at Boston College and received his PhD in Genetics and Biochemistry from the University of Illinois, Urbana, in 1976. He did his undergraduate work at the University of New England and holds a Master's in Genetics from Illinois State University, Normal, IL. He was a postdoctoral fellow and assistant professor in the Yale University School of Medicine neurology department. He presently serves on several editorial boards, including those for Nutrition & Metabolism, Neurochemical Research, the Journal of Lipid Research, and ASN Neuro, where he is a Senior Editor. Dr. Seyfried has over 200 peer-reviewed publications and is the author of the book Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer (Wiley Press). His book was recently translated into Chinese and is now under contract for translation into Turkish. His complete list of peer-reviewed publications can be found on PubMed (https://pubmed.ncbi.nlm.nih.gov).